98 related articles for article (PubMed ID: 25809490)
1. Targeting FAK scaffold functions inhibits human renal cell carcinoma growth.
Béraud C; Dormoy V; Danilin S; Lindner V; Béthry A; Hochane M; Coquard C; Barthelmebs M; Jacqmin D; Lang H; Massfelder T
Int J Cancer; 2015 Oct; 137(7):1549-59. PubMed ID: 25809490
[TBL] [Abstract][Full Text] [Related]
2. The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma.
Hamaidi I; Coquard C; Danilin S; Dormoy V; Béraud C; Rothhut S; Barthelmebs M; Benkirane-Jessel N; Lindner V; Lang H; Massfelder T
Oncogene; 2019 Jan; 38(1):60-72. PubMed ID: 30076415
[TBL] [Abstract][Full Text] [Related]
3. FAK inhibition abrogates the malignant phenotype in aggressive pediatric renal tumors.
Megison ML; Gillory LA; Stewart JE; Nabers HC; Mrozcek-Musulman E; Beierle EA
Mol Cancer Res; 2014 Apr; 12(4):514-26. PubMed ID: 24464916
[TBL] [Abstract][Full Text] [Related]
4. LIM-class homeobox gene Lim1, a novel oncogene in human renal cell carcinoma.
Dormoy V; Béraud C; Lindner V; Thomas L; Coquard C; Barthelmebs M; Jacqmin D; Lang H; Massfelder T
Oncogene; 2011 Apr; 30(15):1753-63. PubMed ID: 21132009
[TBL] [Abstract][Full Text] [Related]
5. FAK Expression, Not Kinase Activity, Is a Key Mediator of Thyroid Tumorigenesis and Protumorigenic Processes.
Kessler BE; Sharma V; Zhou Q; Jing X; Pike LA; Kerege AA; Sams SB; Schweppe RE
Mol Cancer Res; 2016 Sep; 14(9):869-82. PubMed ID: 27259715
[TBL] [Abstract][Full Text] [Related]
6. EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells.
Cho MC; Cho SY; Yoon CY; Lee SB; Kwak C; Kim HH; Jeong H
PLoS One; 2015; 10(7):e0130975. PubMed ID: 26177500
[TBL] [Abstract][Full Text] [Related]
7. Anoikis disruption of focal adhesion-Akt signaling impairs renal cell carcinoma.
Sakamoto S; Schwarze S; Kyprianou N
Eur Urol; 2011 May; 59(5):734-44. PubMed ID: 21269758
[TBL] [Abstract][Full Text] [Related]
8. Targeting the nuclear factor-kappaB rescue pathway has promising future in human renal cell carcinoma therapy.
Sourbier C; Danilin S; Lindner V; Steger J; Rothhut S; Meyer N; Jacqmin D; Helwig JJ; Lang H; Massfelder T
Cancer Res; 2007 Dec; 67(24):11668-76. PubMed ID: 18089796
[TBL] [Abstract][Full Text] [Related]
9. Increased Expression of MicroRNA 551a by c-Fos Reduces Focal Adhesion Kinase Levels and Blocks Tumorigenesis.
Anuj ; Arivazhagan L; Venkatraman G; Rayala SK
Mol Cell Biol; 2019 Apr; 39(7):. PubMed ID: 30670568
[TBL] [Abstract][Full Text] [Related]
10. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
[TBL] [Abstract][Full Text] [Related]
12. Role of the RNA-binding protein HuR in human renal cell carcinoma.
Danilin S; Sourbier C; Thomas L; Lindner V; Rothhut S; Dormoy V; Helwig JJ; Jacqmin D; Lang H; Massfelder T
Carcinogenesis; 2010 Jun; 31(6):1018-26. PubMed ID: 20219773
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of G3BPs inhibits the growth, migration and invasion of human lung carcinoma H1299 cells by suppressing the Src/FAK-associated signaling pathway.
Zhang H; Zhang SH; He HW; Zhang CX; Yu DK; Shao RG
Cancer Gene Ther; 2013 Nov; 20(11):622-9. PubMed ID: 24157923
[TBL] [Abstract][Full Text] [Related]
14. The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells.
Peruzzi B; Athauda G; Bottaro DP
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14531-6. PubMed ID: 16983094
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.
Perier A; Fregni G; Wittnebel S; Gad S; Allard M; Gervois N; Escudier B; Azzarone B; Caignard A
Oncogene; 2011 Jun; 30(23):2622-32. PubMed ID: 21258414
[TBL] [Abstract][Full Text] [Related]
16. Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase.
Brenner W; Greber I; Gudejko-Thiel J; Beitz S; Schneider E; Walenta S; Peters K; Unger R; Thüroff JW
Int J Oncol; 2008 May; 32(5):1125-31. PubMed ID: 18425341
[TBL] [Abstract][Full Text] [Related]
17. The 104-123 amino acid sequence of the beta-domain of von Hippel-Lindau gene product is sufficient to inhibit renal tumor growth and invasion.
Datta K; Sundberg C; Karumanchi SA; Mukhopadhyay D
Cancer Res; 2001 Mar; 61(5):1768-75. PubMed ID: 11280720
[TBL] [Abstract][Full Text] [Related]
18. RNA interference targeting human FAK and EGFR suppresses human non-small-cell lung cancer xenograft growth in nude mice.
Li C; Zhang X; Cheng L; Dai L; Xu F; Zhang J; Tian H; Chen X; Shi G; Li Y; Du T; Zhang S; Wei Y; Deng H
Cancer Gene Ther; 2013 Feb; 20(2):101-8. PubMed ID: 23328701
[TBL] [Abstract][Full Text] [Related]
19. Lord of the rings: a promising novel treatment for renal cell carcinoma?
Johansson M
Eur Urol; 2011 May; 59(5):745-6. PubMed ID: 21276657
[No Abstract] [Full Text] [Related]
20. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y
Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
